Sources of variability in epidemiological studies of sleep using repeated nights of in-home polysomnography: SWAN Sleep Study.

Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
Huiyong ZhengMartica Hall

Abstract

To quantify sources of night-to-night variability. This project was conducted in 285 middle-aged African American, Caucasian, and Chinese women from the Study of Women's Health Across the Nation (SWAN) Sleep Study living in Chicago, the Detroit area, Oakland, and Pittsburgh. The study used 3 repeated nights of in-home polysomnography (PSG) measures. Night 1 data included assessment of sleep staging, sleep apnea, and periodic limb movements, while Nights 2 and 3 focused on sleep staging. Mean total sleep time (TST) increased substantially from 365 minutes on Night 1 to 391 minutes and 380 minutes, respectively, on Nights 2 and 3. Mean percent sleep efficiency (SE%) for the 3 nights were 83%, 85%, and 85%, respectively. Night 1 sleep values were significantly different than Nights 2 and 3 measures except for S2 (%), S1 (min), and Delta (S3+4)%. Nights 2 and 3 differences in variability were negligible. Obesity, past smoking, and financial strain measures were associated with greater Night 1 vs. Night 2 or Night 3 differences. We concluded that there was significant Night 1 vs. Nights 2 and 3 variability and, though relatively modest, it was sufficient to bias estimates of association. Additionally, personal characteristics includ...Continue Reading

References

Jan 1, 1966·Psychophysiology·H W AgnewR L Williams
Jul 20, 2001·Journal of Psychiatric Research·O Le BonP Linkowski
Dec 1, 1964·Perceptual and Motor Skills·A RECHTSCHAFFEN, P VERDONE
Oct 7, 2003·Psychiatry Research·Olivier Le BonPaul Linkowski
Oct 29, 2003·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·S ScholleG Zwacka
Dec 4, 2004·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Stephanie SuDana Suskind
Mar 3, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Masatomo SuetsugiYoshifumi Watanabe
Sep 8, 2007·Atlas of the Oral and Maxillofacial Surgery Clinics of North America·Mansoor MadaniFarideh Madani
May 13, 2008·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Emilia SforzaAlain Buguet
Mar 21, 2009·American Journal of Epidemiology·Patrick M Krueger, Elliot M Friedman

❮ Previous
Next ❯

Citations

Jun 4, 2014·BJOG : an International Journal of Obstetrics and Gynaecology·L M O'BrienR D Chervin
May 15, 2013·Sleep Medicine Reviews·Simon A JoostenGarun S Hamilton
Jul 11, 2018·American Journal of Physical Anthropology·Gandhi YetishMichael Gurven
Jan 30, 2020·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Ingo FietzeThomas Penzel
May 14, 2016·Climacteric : the Journal of the International Menopause Society·A HiroseT Kubota
Jun 2, 2015·Nature Neuroscience·Bryce A ManderMatthew P Walker
Aug 4, 2015·Sleep·Jordan GainesEdward O Bixler
Oct 5, 2016·Behavioral Sleep Medicine·Irina VirtanenPäivi Polo-Kantola
Jan 23, 2018·NPJ Parkinson's Disease·Sarah McGregorMalcolm Horne
Jan 11, 2019·Science Translational Medicine·Brendan P LuceyDavid M Holtzman
Oct 2, 2019·Journal of Research on Adolescence : the Official Journal of the Society for Research on Adolescence·Madeleine J GeorgeCandice L Odgers
Mar 31, 2021·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Samuel TschoppKurt Tschopp

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.